-+ 0.00%
-+ 0.00%
-+ 0.00%

TONIX PHARMACEUTICALS ANNOUNCES ISSUANCE OF U.S. PATENT COVERING THE SUBCUTANEOUS DELIVERY OF FDA-APPROVED ZEMBRACE® SYMTOUCH® TO TREAT MIGRAINES

Reuters·09/27/2024 11:00:00
Listen to the news
TONIX PHARMACEUTICALS ANNOUNCES ISSUANCE OF U.S. PATENT COVERING THE SUBCUTANEOUS DELIVERY OF FDA-APPROVED ZEMBRACE® SYMTOUCH® TO TREAT MIGRAINES